cupure logo
trumpukrainetalkspopewarceasefireputinchinapeaceleo

Zepbound beats Wegovy rival in 1st head-to-head weight loss study

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

Comments

World news